Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 06, 2023 Filed Mar 9, 2023 01:00 UTC |
Rodino-Klapac LouiseHead of R&D, CSO
|
GrantStock Option (right to buy) · Derivative | 27,000 | $0.00 Strike: $155.99 | $0.00 |
DisclosureSEC source: 0001209191-23-017407 · doc4.xml · derivative · entry 3 Rodino-Klapac Louise · CIK 0001836218 · Head of R&D, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,000 Underlying: Common Stock · 27,000 shares Expires 2033-03-06 F3 · derivative.exercise_date: Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and become exercisable on each monthly anniversary thereafter. Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 01:00 UTC |
Rodino-Klapac LouiseHead of R&D, CSO
|
GrantCommon Stock | 4,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-017407 · doc4.xml · nonDerivative · entry 2 Rodino-Klapac Louise · CIK 0001836218 · Head of R&D, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,082 F2 · price: The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest on the first anniversary of the grant date, and additional 25% will vest on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested on the fourth anniversary of the grant date. Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 01:00 UTC |
Rodino-Klapac LouiseHead of R&D, CSO
|
Tax withholdingCommon Stock | 1,134 | $157.21 | $178,276.14 |
DisclosureSEC source: 0001209191-23-017407 · doc4.xml · nonDerivative · entry 1 Rodino-Klapac Louise · CIK 0001836218 · Head of R&D, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,582 F1 · shares: Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 3, 2021. Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 01:00 UTC |
Estepan Ian MichaelChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 27,000 | $0.00 Strike: $155.99 | $0.00 |
DisclosureSEC source: 0001209191-23-017408 · doc4.xml · derivative · entry 3 Estepan Ian Michael · CIK 0001836254 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,000 Underlying: Common Stock · 27,000 shares Expires 2033-03-06 F3 · derivative.exercise_date: Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and become exercisable on each monthly anniversary thereafter. Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 01:00 UTC |
Estepan Ian MichaelChief Financial Officer
|
GrantCommon Stock | 4,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-017408 · doc4.xml · nonDerivative · entry 2 Estepan Ian Michael · CIK 0001836254 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,423 F2 · price: The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest on the first anniversary of the grant date, and additional 25% will vest on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested on the fourth anniversary of the grant date. Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 01:00 UTC |
Estepan Ian MichaelChief Financial Officer
|
Tax withholdingCommon Stock | 1,370 | $157.21 | $215,377.70 |
DisclosureSEC source: 0001209191-23-017408 · doc4.xml · nonDerivative · entry 1 Estepan Ian Michael · CIK 0001836254 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,923 F1 · shares: Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 3, 2021. Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 01:00 UTC |
BEHRENS M KATHLEENDirector
|
GrantStock Option (right to buy) · Derivative | 3,257 | $0.00 Strike: $155.99 | $0.00 |
DisclosureSEC source: 0001209191-23-017402 · doc4.xml · derivative · entry 3 BEHRENS M KATHLEEN · CIK 0001211701 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,257 Underlying: Common Stock · 3,257 shares Expires 2033-03-06 Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 01:00 UTC |
BEHRENS M KATHLEENDirector
|
GrantCommon Stock | 1,523 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-017402 · doc4.xml · nonDerivative · entry 1 BEHRENS M KATHLEEN · CIK 0001211701 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,993 F1 · price: The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 6, 2024. Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 01:00 UTC |
Barry RichardDirector
|
GrantStock Option (right to buy) · Derivative | 3,257 | $0.00 Strike: $155.99 | $0.00 |
DisclosureSEC source: 0001209191-23-017401 · doc4.xml · derivative · entry 3 Barry Richard · CIK 0001562371 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,257 Underlying: Common Stock · 3,257 shares Expires 2033-03-06 Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 01:00 UTC |
Barry RichardDirector
|
GrantCommon Stock | 1,523 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-017401 · doc4.xml · nonDerivative · entry 1 Barry Richard · CIK 0001562371 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,929,842 F1 · price: The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 6, 2024. Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 01:00 UTC |
Brown Ryan EdwardSVP, General Counsel
|
GrantStock Option (right to buy) · Derivative | 27,000 | $0.00 Strike: $155.99 | $0.00 |
DisclosureSEC source: 0001209191-23-017400 · doc4.xml · derivative · entry 4 Brown Ryan Edward · CIK 0001848718 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,000 Underlying: Common Stock · 27,000 shares Expires 2033-03-06 F4 · derivative.exercise_date: Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and become exercisable on each monthly anniversary thereafter. Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 01:00 UTC |
Brown Ryan EdwardSVP, General Counsel
|
GrantCommon Stock | 4,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-017400 · doc4.xml · nonDerivative · entry 3 Brown Ryan Edward · CIK 0001848718 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,820 F3 · price: The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest on the first anniversary of the grant date, and additional 25% will vest on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested on the fourth anniversary of the grant date. Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 01:00 UTC |
Brown Ryan EdwardSVP, General Counsel
|
Tax withholdingCommon Stock | 171 | $157.21 | $26,882.91 |
DisclosureSEC source: 0001209191-23-017400 · doc4.xml · nonDerivative · entry 2 Brown Ryan Edward · CIK 0001848718 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,320 F2 · shares: Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 4, 2019. Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 01:00 UTC |
Brown Ryan EdwardSVP, General Counsel
|
Tax withholdingCommon Stock | 1,154 | $157.21 | $181,420.34 |
DisclosureSEC source: 0001209191-23-017400 · doc4.xml · nonDerivative · entry 1 Brown Ryan Edward · CIK 0001848718 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,491 F1 · shares: Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 3, 2021. Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 01:00 UTC |
Chambers Michael AndrewDirector
|
GrantStock Option (right to buy) · Derivative | 3,257 | $0.00 Strike: $155.99 | $0.00 |
DisclosureSEC source: 0001209191-23-017406 · doc4.xml · derivative · entry 3 Chambers Michael Andrew · CIK 0001932527 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,257 Underlying: Common Stock · 3,257 shares Expires 2033-03-06 Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 01:00 UTC |
Chambers Michael AndrewDirector
|
GrantCommon Stock | 1,523 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-017406 · doc4.xml · nonDerivative · entry 1 Chambers Michael Andrew · CIK 0001932527 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,431 F1 · price: The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 6, 2024. Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 01:00 UTC |
Nicaise ClaudeDirector
|
GrantStock Option (right to buy) · Derivative | 3,257 | $0.00 Strike: $155.99 | $0.00 |
DisclosureSEC source: 0001209191-23-017405 · doc4.xml · derivative · entry 2 Nicaise Claude · CIK 0001644162 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,257 Underlying: Common Stock · 3,257 shares Expires 2033-03-06 Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 01:00 UTC |
Nicaise ClaudeDirector
|
GrantCommon Stock | 1,523 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-017405 · doc4.xml · nonDerivative · entry 1 Nicaise Claude · CIK 0001644162 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,328 F1 · price: The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 6, 2024. Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 01:00 UTC |
Boor Kathryn JeanDirector
|
GrantStock Option (right to buy) · Derivative | 3,257 | $0.00 Strike: $155.99 | $0.00 |
DisclosureSEC source: 0001209191-23-017399 · doc4.xml · derivative · entry 2 Boor Kathryn Jean · CIK 0001761826 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,257 Underlying: Common Stock · 3,257 shares Expires 2033-03-06 Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 01:00 UTC |
Boor Kathryn JeanDirector
|
GrantCommon Stock | 1,523 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-017399 · doc4.xml · nonDerivative · entry 1 Boor Kathryn Jean · CIK 0001761826 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,431 F1 · price: The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 6, 2024. Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 01:00 UTC |
Mayo StephenDirector
|
GrantStock Option (right to buy) · Derivative | 3,257 | $0.00 Strike: $155.99 | $0.00 |
DisclosureSEC source: 0001209191-23-017394 · doc4.xml · derivative · entry 2 Mayo Stephen · CIK 0001849061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,257 Underlying: Common Stock · 3,257 shares Expires 2033-03-06 Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 01:00 UTC |
Mayo StephenDirector
|
GrantCommon Stock | 1,523 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-017394 · doc4.xml · nonDerivative · entry 1 Mayo Stephen · CIK 0001849061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,910 F1 · price: The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 6, 2024. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 01:01 UTC |
Arif BilalChief Tech Ops Officer
|
Tax withholdingCommon Stock | 172 | $147.57 | $25,382.04 |
DisclosureSEC source: 0001209191-23-016058 · doc4.xml · nonDerivative · entry 2 Arif Bilal · CIK 0001959750 · Chief Tech Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,828 F1 · shares: Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on February 28, 2020. F2 · balance_after: Amount of Securities Beneficially Owned includes 163 shares purchased under the Company's registered Employee Stock Purchase Plan on February 28, 2023. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 01:01 UTC |
Arif BilalChief Tech Ops Officer
|
Tax withholdingCommon Stock | 80 | $147.57 | $11,805.60 |
DisclosureSEC source: 0001209191-23-016058 · doc4.xml · nonDerivative · entry 1 Arif Bilal · CIK 0001959750 · Chief Tech Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,837 F1 · shares: Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on February 28, 2020. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 01:01 UTC |
Brown Ryan EdwardSVP, General Counsel
|
Tax withholdingCommon Stock | 196 | $147.57 | $28,923.72 |
DisclosureSEC source: 0001209191-23-016057 · doc4.xml · nonDerivative · entry 1 Brown Ryan Edward · CIK 0001848718 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,645 F1 · shares: Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on 02/28/2020. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 01:00 UTC |
Rodino-Klapac LouiseHead of R&D, CSO
|
Tax withholdingCommon Stock | 522 | $147.57 | $77,031.54 |
DisclosureSEC source: 0001209191-23-016054 · doc4.xml · nonDerivative · entry 1 Rodino-Klapac Louise · CIK 0001836218 · Head of R&D, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,716 F1 · shares: Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on February 28, 2020. F2 · balance_after: Amount of Securities Beneficially Owned includes 240 shares purchased under the Company's registered Employee Stock Purchase Plan on February 28, 2023. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 01:00 UTC |
Estepan Ian MichaelChief Financial Officer
|
Tax withholdingCommon Stock | 378 | $147.57 | $55,781.46 |
DisclosureSEC source: 0001209191-23-016055 · doc4.xml · nonDerivative · entry 1 Estepan Ian Michael · CIK 0001836254 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,293 F1 · shares: Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on February 28, 2020. Read SEC document |
| December 31, 2022 Filed Jan 5, 2023 01:03 UTC |
Arif BilalChief Tech Ops Officer
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $129.58 | $0.00 |
DisclosureSEC source: 0001209191-23-001464 · doc4.xml · derivative · entry 1 Arif Bilal · CIK 0001959750 · Chief Tech Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2032-12-31 Read SEC document |
| December 19, 2022 Filed Dec 21, 2022 14:05 UTC |
BEHRENS M KATHLEENDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $34.92 | $0.00 |
DisclosureSEC source: 0001209191-22-062287 · doc4.xml · derivative · entry 3 BEHRENS M KATHLEEN · CIK 0001211701 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2023-06-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 19, 2022 Filed Dec 21, 2022 14:05 UTC |
BEHRENS M KATHLEENDirector
|
Exercise / conversionCommon Stock | 20,000 | $34.92 | $698,400.00 |
DisclosureSEC source: 0001209191-22-062287 · doc4.xml · nonDerivative · entry 1 BEHRENS M KATHLEEN · CIK 0001211701 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,470 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 17, 2022 Filed Nov 22, 2022 01:02 UTC |
Rodino-Klapac LouiseHead of R&D, CSO
|
Tax withholdingCommon Stock | 4,211 | $108.52 | $456,977.72 |
DisclosureSEC source: 0001209191-22-058284 · doc4.xml · nonDerivative · entry 1 Rodino-Klapac Louise · CIK 0001836218 · Head of R&D, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,998 F1 · shares: Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on November 16, 2021. F2 · balance_after: Amount of Securities Beneficially Owned includes 98 shares purchased under the Company's registered Employee Stock Purchase Plan on August 31, 2022. Read SEC document |
| November 17, 2022 Filed Nov 22, 2022 01:00 UTC |
Mayo StephenDirector
|
SaleCommon Stock | 858 | $109.92 | $94,311.36 |
DisclosureSEC source: 0001209191-22-058283 · doc4.xml · nonDerivative · entry 1 Mayo Stephen · CIK 0001849061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,387 F1 · shares: Represents a sale of shares of common stock to generate cash for the payment of taxes due as a result of the vesting of certain restricted stock unit awards. Read SEC document |
| September 14, 2022 Filed Sep 15, 2022 12:00 UTC |
Chambers Michael AndrewDirector
|
PurchaseCommon Stock | 6,250 | $105.16 | $657,250.00 |
DisclosureSEC source: 0001209191-22-050002 · doc4.xml · nonDerivative · entry 3 Chambers Michael Andrew · CIK 0001932527 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,178 F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $105.085 to $105.40, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. Read SEC document |
| September 14, 2022 Filed Sep 15, 2022 12:00 UTC |
Chambers Michael AndrewDirector
|
PurchaseCommon Stock | 30,106 | $104.67 | $3,151,195.02 |
DisclosureSEC source: 0001209191-22-050002 · doc4.xml · nonDerivative · entry 2 Chambers Michael Andrew · CIK 0001932527 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,928 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $104.065 to $105.05, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. Read SEC document |
| September 14, 2022 Filed Sep 15, 2022 12:00 UTC |
Chambers Michael AndrewDirector
|
PurchaseCommon Stock | 20,744 | $103.87 | $2,154,679.28 |
DisclosureSEC source: 0001209191-22-050002 · doc4.xml · nonDerivative · entry 1 Chambers Michael Andrew · CIK 0001932527 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,822 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $103.06 to $104.05, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. Read SEC document |
| September 13, 2022 Filed Sep 14, 2022 12:00 UTC |
Chambers Michael AndrewDirector
|
GrantConvertible Senior Notes · Derivative | Not disclosed | $20,000,000.00 Strike: $141.97 | $20,000,000.00 |
DisclosureSEC source: 0001209191-22-049820 · doc4.xml · derivative · entry 1 Chambers Michael Andrew · CIK 0001932527 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Revocable Trust Disclosed balance after: Not disclosed Underlying: Common Stock · 140,879 shares Expires not disclosed F1 · date: On September 13, 2022, the Reporting Person and the Company entered into a purchase agreement related to a purchase by the Reporting Person of $20,000,000 in aggregate principal amount of the Company's 1.25% Convertible Senior Notes due 2027 (the "2027 Notes") in a private placement from the Company. The private placement is expected to close on September 16, 2022, subject to customary closing conditions. F1 · kind: On September 13, 2022, the Reporting Person and the Company entered into a purchase agreement related to a purchase by the Reporting Person of $20,000,000 in aggregate principal amount of the Company's 1.25% Convertible Senior Notes due 2027 (the "2027 Notes") in a private placement from the Company. The private placement is expected to close on September 16, 2022, subject to customary closing conditions. F2 · derivative.exercise_date: The 2027 Notes are convertible at the election of the holder at any time prior to the close of business on the business day immediately preceding March 15, 2027, provided that certain convertibility conditions are met. On or after March 15, 2027 until the close of business on the second scheduled trading day immediately preceding the maturity date (September 15, 2027), holders may convert their notes at any time, regardless of the foregoing circumstances. Any conversion of the 2027 Notes may be settled in shares of Common Stock, cash or a combination of cash and shares of Common Stock at the Company's election. F2 · derivative.expiration_date: The 2027 Notes are convertible at the election of the holder at any time prior to the close of business on the business day immediately preceding March 15, 2027, provided that certain convertibility conditions are met. On or after March 15, 2027 until the close of business on the second scheduled trading day immediately preceding the maturity date (September 15, 2027), holders may convert their notes at any time, regardless of the foregoing circumstances. Any conversion of the 2027 Notes may be settled in shares of Common Stock, cash or a combination of cash and shares of Common Stock at the Company's election. F2 · derivative.underlying_shares: The 2027 Notes are convertible at the election of the holder at any time prior to the close of business on the business day immediately preceding March 15, 2027, provided that certain convertibility conditions are met. On or after March 15, 2027 until the close of business on the second scheduled trading day immediately preceding the maturity date (September 15, 2027), holders may convert their notes at any time, regardless of the foregoing circumstances. Any conversion of the 2027 Notes may be settled in shares of Common Stock, cash or a combination of cash and shares of Common Stock at the Company's election. Read SEC document |
| August 19, 2022 Filed Aug 22, 2022 12:30 UTC |
Chambers Michael AndrewDirector
|
PurchaseCommon Stock | 6,060 | $108.80 | $659,328.00 |
DisclosureSEC source: 0001209191-22-046973 · doc4.xml · nonDerivative · entry 2 Chambers Michael Andrew · CIK 0001932527 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,078 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $108.57 to $109.05, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. Read SEC document |
| August 19, 2022 Filed Aug 22, 2022 12:30 UTC |
Chambers Michael AndrewDirector
|
PurchaseCommon Stock | 40,110 | $108.20 | $4,339,902.00 |
DisclosureSEC source: 0001209191-22-046973 · doc4.xml · nonDerivative · entry 1 Chambers Michael Andrew · CIK 0001932527 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,018 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $107.56 to $108.56, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. Read SEC document |
| June 02, 2022 Filed Jun 7, 2022 00:24 UTC |
Boor Kathryn JeanDirector
|
GrantStock Option (right to buy) · Derivative | 8,329 | $0.00 Strike: $72.58 | $0.00 |
DisclosureSEC source: 0001209191-22-034740 · doc4.xml · derivative · entry 2 Boor Kathryn Jean · CIK 0001761826 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,329 Underlying: Common Stock · 8,329 shares Expires 2032-06-02 F2 · derivative.exercise_date: The option vests in three equal annual installments beginning June 2, 2023. Read SEC document |
| June 02, 2022 Filed Jun 7, 2022 00:24 UTC |
Boor Kathryn JeanDirector
|
GrantCommon Stock | 4,908 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034740 · doc4.xml · nonDerivative · entry 1 Boor Kathryn Jean · CIK 0001761826 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,908 F1 · price: The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs vest in three equal annual installments beginning June 2, 2023. Read SEC document |
| June 02, 2022 Filed Jun 7, 2022 00:22 UTC |
Chambers Michael AndrewDirector
|
GrantStock Option (right to buy) · Derivative | 8,329 | $0.00 Strike: $72.58 | $0.00 |
DisclosureSEC source: 0001209191-22-034739 · doc4.xml · derivative · entry 3 Chambers Michael Andrew · CIK 0001932527 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,329 Underlying: Common Stock · 8,329 shares Expires 2032-06-02 F2 · derivative.exercise_date: The option vests in three equal annual installments beginning June 2, 2023. Read SEC document |
| June 02, 2022 Filed Jun 7, 2022 00:22 UTC |
Chambers Michael AndrewDirector
|
GrantCommon Stock | 4,908 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034739 · doc4.xml · nonDerivative · entry 1 Chambers Michael Andrew · CIK 0001932527 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,908 F1 · price: The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs vest in three equal annual installments beginning June 2, 2023. Read SEC document |
| June 01, 2022 Filed Jun 4, 2022 00:00 UTC |
Brown Ryan EdwardSVP, General Counsel
|
Tax withholdingCommon Stock | 54 | $72.67 | $3,924.18 |
DisclosureSEC source: 0001209191-22-034380 · doc4.xml · nonDerivative · entry 1 Brown Ryan Edward · CIK 0001848718 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,841 F1 · shares: Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on May 31, 2019. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 01:07 UTC |
Nicaise ClaudeDirector
|
GrantStock Option (right to buy) · Derivative | 5,077 | $0.00 Strike: $80.42 | $0.00 |
DisclosureSEC source: 0001209191-22-017353 · doc4.xml · derivative · entry 2 Nicaise Claude · CIK 0001644162 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,077 Underlying: Common Stock · 5,077 shares Expires 2032-03-07 Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 01:07 UTC |
Nicaise ClaudeDirector
|
GrantCommon Stock | 2,953 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-017353 · doc4.xml · nonDerivative · entry 1 Nicaise Claude · CIK 0001644162 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,805 F1 · price: The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 7, 2023. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 01:06 UTC |
GRAY MARY ANNDirector
|
GrantStock Option (right to buy) · Derivative | 5,077 | $0.00 Strike: $80.42 | $0.00 |
DisclosureSEC source: 0001209191-22-017352 · doc4.xml · derivative · entry 2 GRAY MARY ANN · CIK 0001261974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,077 Underlying: Common Stock · 5,077 shares Expires 2032-03-07 Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 01:06 UTC |
GRAY MARY ANNDirector
|
GrantCommon Stock | 2,953 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-017352 · doc4.xml · nonDerivative · entry 1 GRAY MARY ANN · CIK 0001261974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,356 F1 · price: The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 7, 2023. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 01:05 UTC |
Wigzell Hans Lennart RudolfDirector
|
GrantStock Option (right to buy) · Derivative | 5,077 | $0.00 Strike: $80.42 | $0.00 |
DisclosureSEC source: 0001209191-22-017350 · doc4.xml · derivative · entry 2 Wigzell Hans Lennart Rudolf · CIK 0001492766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,077 Underlying: Common Stock · 5,077 shares Expires 2032-03-07 Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 01:05 UTC |
Wigzell Hans Lennart RudolfDirector
|
GrantCommon Stock | 2,953 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-017350 · doc4.xml · nonDerivative · entry 1 Wigzell Hans Lennart Rudolf · CIK 0001492766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,471 F1 · price: The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 7, 2023. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 01:04 UTC |
BEHRENS M KATHLEENDirector
|
GrantStock Option (right to buy) · Derivative | 5,077 | $0.00 Strike: $80.42 | $0.00 |
DisclosureSEC source: 0001209191-22-017349 · doc4.xml · derivative · entry 3 BEHRENS M KATHLEEN · CIK 0001211701 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,077 Underlying: Common Stock · 5,077 shares Expires 2032-03-07 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.